Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Authors' Reply.

Assimon MM, Flythe JE.

J Am Soc Nephrol. 2019 Jun 3. pii: ASN.2019040431. doi: 10.1681/ASN.2019040431. [Epub ahead of print] No abstract available.

PMID:
31160516
2.

Cumulative Exposure to Frequent Intradialytic Hypotension Associates With New-Onset Dementia Among Elderly Hemodialysis Patients.

Assimon MM, Wang L, Flythe JE.

Kidney Int Rep. 2019 Jan 14;4(4):603-606. doi: 10.1016/j.ekir.2019.01.001. eCollection 2019 Apr. No abstract available.

3.

Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.

Assimon MM, Brookhart MA, Flythe JE.

J Am Soc Nephrol. 2019 Apr;30(4):611-623. doi: 10.1681/ASN.2018101032. Epub 2019 Mar 18.

PMID:
30885935
4.

Failed Target Weight Achievement Associates with Short-Term Hospital Encounters among Individuals Receiving Maintenance Hemodialysis.

Assimon MM, Wang L, Flythe JE.

J Am Soc Nephrol. 2018 Aug;29(8):2178-2188. doi: 10.1681/ASN.2018010004. Epub 2018 May 23.

PMID:
29793962
5.

A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.

Assimon MM, Brookhart MA, Fine JP, Heiss G, Layton JB, Flythe JE.

Am J Kidney Dis. 2018 Sep;72(3):337-348. doi: 10.1053/j.ajkd.2018.02.350. Epub 2018 Apr 10.

PMID:
29653770
6.

Intradialytic Hypertension Frequency and Short-Term Clinical Outcomes Among Individuals Receiving Maintenance Hemodialysis.

Assimon MM, Wang L, Flythe JE.

Am J Hypertens. 2018 Feb 9;31(3):329-339. doi: 10.1093/ajh/hpx186.

7.

Thirty-Day Hospital Readmissions in the Hemodialysis Population: A Problem Well Put, But Half-Solved.

Assimon MM, Flythe JE.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1566-1568. doi: 10.2215/CJN.08810817. Epub 2017 Sep 28. No abstract available.

8.

Definitions of intradialytic hypotension.

Assimon MM, Flythe JE.

Semin Dial. 2017 Nov;30(6):464-472. doi: 10.1111/sdi.12626. Epub 2017 Jul 9.

9.

Target weight achievement and ultrafiltration rate thresholds: potential patient implications.

Flythe JE, Assimon MM, Overman RA.

BMC Nephrol. 2017 Jun 2;18(1):185. doi: 10.1186/s12882-017-0595-5.

10.

Ultrafiltration Rate Scaling in Hemodialysis Patients.

Flythe JE, Assimon MM, Wang L.

Semin Dial. 2017 May;30(3):282-283. doi: 10.1111/sdi.12602. Epub 2017 Apr 7. No abstract available.

11.

Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study.

Assimon MM, Nguyen T, Katsanos SL, Brunelli SM, Flythe JE.

BMC Nephrol. 2016 Nov 11;17(1):173.

12.

Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients.

Assimon MM, Wenger JB, Wang L, Flythe JE.

Am J Kidney Dis. 2016 Dec;68(6):911-922. doi: 10.1053/j.ajkd.2016.06.020. Epub 2016 Aug 26.

13.

Ultrafiltration Rates and the Quality Incentive Program: Proposed Measure Definitions and Their Potential Dialysis Facility Implications.

Flythe JE, Assimon MM, Wenger JB, Wang L.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1422-33. doi: 10.2215/CJN.13441215. Epub 2016 Jun 22.

14.

Variability May Be the "Law of Life," but Blood Pressure Variability May Forebode a Shorter Life.

Assimon MM, Flythe JE.

Am J Kidney Dis. 2016 Jun;67(6):830-3. doi: 10.1053/j.ajkd.2016.01.014. Epub 2016 Feb 18. No abstract available.

15.

Intradialytic Blood Pressure Abnormalities: The Highs, The Lows and All That Lies Between.

Assimon MM, Flythe JE.

Am J Nephrol. 2015;42(5):337-50. doi: 10.1159/000441982. Epub 2015 Nov 20. Review.

16.

Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base.

Assimon MM, Flythe JE.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):525-30. doi: 10.1097/MNH.0000000000000174. Review.

17.

Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity.

Patel N, Assimon MM, Bruni E, McNutt LA, Mason DL.

South Med J. 2015 Sep;108(9):567-73. doi: 10.14423/SMJ.0000000000000343.

PMID:
26332483
18.

Observation stays in administrative claims databases: underestimation of hospitalized cases.

Overman RA, Freburger JK, Assimon MM, Li X, Brookhart MA.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):902-10. doi: 10.1002/pds.3647. Epub 2014 May 28.

19.

Nervous system autoantibodies and vitamin D receptor gene polymorphisms in hemodialysis patients.

Mason DL, Assimon MM, Bishop JR, El-Fawal HA.

Hemodial Int. 2013 Jan;17(1):3-11. doi: 10.1111/j.1542-4758.2012.00727.x. Epub 2012 Aug 15.

20.

Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit?

Assimon MM, Salenger PV, El-Fawal HA, Mason DL.

Nephrology (Carlton). 2012 Mar;17(3):237-42. doi: 10.1111/j.1440-1797.2011.01555.x.

PMID:
22181351
21.

Medication-related problems in CKD.

Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ.

Adv Chronic Kidney Dis. 2010 Sep;17(5):404-12. doi: 10.1053/j.ackd.2010.06.004. Review.

PMID:
20727510
22.

The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.

Assimon MM, Mousa S, Shaker O, Pai AB.

Consult Pharm. 2010 Jan;25(1):41-54. doi: 10.4140/TCP.n.2010.41. Review.

PMID:
20211816

Supplemental Content

Loading ...
Support Center